| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Benign outcome among positive cystic fibrosis newborn screen children with non-CF-causing variants
|
Salinas, Danieli Barino
|
|
2015
|
14 |
6 |
p. 714-719
6 p.
|
artikel
|
| 2 |
Comparison of health-related quality of life among children with cystic fibrosis and their parents in two Eastern European countries
|
Borawska-Kowalczyk, Urszula
|
|
2015
|
14 |
6 |
p. 798-804
7 p.
|
artikel
|
| 3 |
Concentration of fractional excretion of nitric oxide (FENO): A potential airway biomarker of restored CFTR function
|
Kotha, Kavitha
|
|
2015
|
14 |
6 |
p. 733-740
8 p.
|
artikel
|
| 4 |
Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID): A new designation and management recommendations for infants with an inconclusive diagnosis following newborn screening
|
Munck, A.
|
|
2015
|
14 |
6 |
p. 706-713
8 p.
|
artikel
|
| 5 |
Editorial Board
|
|
|
2015
|
14 |
6 |
p. ii-
1 p.
|
artikel
|
| 6 |
Effect of ivacaftor therapy on exhaled nitric oxide in patients with cystic fibrosis
|
Grasemann, Hartmut
|
|
2015
|
14 |
6 |
p. 727-732
6 p.
|
artikel
|
| 7 |
Estimating body composition from skinfold thicknesses and bioelectrical impedance analysis in cystic fibrosis patients
|
Alicandro, Gianfranco
|
|
2015
|
14 |
6 |
p. 784-791
8 p.
|
artikel
|
| 8 |
Factors associated with response to treatment of pulmonary exacerbations in cystic fibrosis patients
|
Waters, Valerie J.
|
|
2015
|
14 |
6 |
p. 755-762
8 p.
|
artikel
|
| 9 |
Finding new drugs to enhance anion secretion in cystic fibrosis: Toward suitable systems for better drug screening. Report on the pre-conference meeting to the 12th ECFS Basic Science Conference, Albufeira, 25–28 March 2015
|
Verkman, Alan S.
|
|
2015
|
14 |
6 |
p. 700-705
6 p.
|
artikel
|
| 10 |
Hallmarks of therapeutic management of the cystic fibrosis functional landscape
|
Amaral, Margarida D.
|
|
2015
|
14 |
6 |
p. 687-699
13 p.
|
artikel
|
| 11 |
Insulin secretion abnormalities in exocrine pancreatic sufficient cystic fibrosis patients
|
Wooldridge, Jamie L.
|
|
2015
|
14 |
6 |
p. 792-797
6 p.
|
artikel
|
| 12 |
News
|
Quittner, Alexandra
|
|
2015
|
14 |
6 |
p. 685-686
2 p.
|
artikel
|
| 13 |
Physical activity assessment in cystic fibrosis: A position statement
|
Bradley, Judy
|
|
2015
|
14 |
6 |
p. e25-e32
nvt p.
|
artikel
|
| 14 |
Prolongation of antibiotic treatment for cystic fibrosis pulmonary exacerbations
|
Waters, Valerie
|
|
2015
|
14 |
6 |
p. 770-776
7 p.
|
artikel
|
| 15 |
Proximity to blue spaces and risk of infection with Pseudomonas aeruginosa in cystic fibrosis: A case–control analysis
|
Goeminne, Pieter C.
|
|
2015
|
14 |
6 |
p. 741-747
7 p.
|
artikel
|
| 16 |
Randomized trial of efficacy and safety of dornase alfa delivered by eRapid nebulizer in cystic fibrosis patients
|
Sawicki, Gregory S.
|
|
2015
|
14 |
6 |
p. 777-783
7 p.
|
artikel
|
| 17 |
Should we monitor exhaled NO to assess the restoration of CFTR function in CF patients?
|
Dinh-Xuan, Anh Tuan
|
|
2015
|
14 |
6 |
p. 683-684
2 p.
|
artikel
|
| 18 |
Sorting out the gray zone: Cystic fibrosis newborn screening
|
McColley, Susanna A.
|
|
2015
|
14 |
6 |
p. 681-682
2 p.
|
artikel
|
| 19 |
The epidemiology of poor outcomes after pulmonary exacerbations
|
Sanders, Don B.
|
|
2015
|
14 |
6 |
p. 679-680
2 p.
|
artikel
|
| 20 |
The ideal and the real world of mental health care delivery
|
Ullrich, Gerald
|
|
2015
|
14 |
6 |
p. e33-e34
nvt p.
|
artikel
|
| 21 |
The influence of breathing mode on tobramycin serum levels using the I-neb AAD system in adults with cystic fibrosis
|
van Velzen, A.J.
|
|
2015
|
14 |
6 |
p. 748-754
7 p.
|
artikel
|
| 22 |
The microbiology of the cystic fibrosis upper and lower airway
|
Dosanjh, Amrita
|
|
2015
|
14 |
6 |
p. e35-
1 p.
|
artikel
|
| 23 |
Treatment and demographic factors affecting time to next pulmonary exacerbation in cystic fibrosis
|
VanDevanter, Donald R.
|
|
2015
|
14 |
6 |
p. 763-769
7 p.
|
artikel
|
| 24 |
Use of ibuprofen to assess inflammatory biomarkers in induced sputum: Implications for clinical trials in cystic fibrosis
|
Chmiel, James F.
|
|
2015
|
14 |
6 |
p. 720-726
7 p.
|
artikel
|
Tijdschrift beschrijving